#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1614166	B	PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory)		34,209	ALA1201862	single protein format	PubChem BioAssays
2.	ALA1614249	B	PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]	Equus caballus	42,059	ALA1201862	single protein format	PubChem BioAssays
3.	ALA1614309	F	PUBCHEM_BIOASSAY: Dose response cell-based high-throughput screening assay for agonists of the transient receptor potential channel ML3 (TRPML3). (Class of assay: confirmatory) [Related pubchem assays: 1526, 1424, 1448 ]	Homo sapiens	188	ALA1201862	cell-based format	PubChem BioAssays
4.	ALA1614458	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]	Homo sapiens	75,376	ALA1201862	assay format	PubChem BioAssays
5.	ALA1614516	F	PUBCHEM_BIOASSAY: Fluorescence counterscreen assay for TRPML3 agonists: dose response cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1). (Class of assay: confirmatory) [Related pubchem assays: 1526, 1424, 1448 ]	Danio rerio	188	ALA1201862	cell-based format	PubChem BioAssays
6.	ALA1738312	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391]	Homo sapiens	55,525	ALA1201862	assay format	PubChem BioAssays
7.	ALA1737994	F	PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]		15,530	ALA1201862	assay format	PubChem BioAssays
8.	ALA1741321	F	PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active		16,572	ALA1201862	assay format	PubChem BioAssays
9.	ALA1741322	F	PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active		16,572	ALA1201862	assay format	PubChem BioAssays
10.	ALA1741323	F	PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active		16,572	ALA1201862	assay format	PubChem BioAssays
11.	ALA1741324	F	PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active		16,572	ALA1201862	assay format	PubChem BioAssays
12.	ALA1741325	F	PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active		16,572	ALA1201862	assay format	PubChem BioAssays
13.	ALA2114861	F	PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory)		26,907	ALA1201862	assay format	PubChem BioAssays
14.	ALA2114817	F	PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory)		17,358	ALA1201862	assay format	PubChem BioAssays
15.	ALA2354287	F	PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory)		39,968	ALA1201862	assay format	PubChem BioAssays